Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 30 for “"MPNSTs"”.
-
Therapeutic Targeting Of Bmp2 In Nf1-Deficient Malignant Peripheral Nerve Sheath Tumors (mpnsts)
… signaling pathway as a therapeutic target in MPNSTs, independent of the NRAS and MEK1/2 regulation. The overall goal of my research was to validate the significance of BMP2 in MPNSTs in novel cellular models, study the combinatorial effects of BMP2 and MEK1/2 inhibition, and use the regulation …
-
Mechanistic and Therapeutic Insights for Epigenetic Regulation in Cancer Development
Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are highly aggressive sarcomas that develop sporadically or in patients with Neurofibromatosis type 1 (NF1). Effective treatment options are lacking, and MPNSTs are typically fatal. To gain insights into MPNST pathogenesis, we utilized a novel MPNST …
-
Development of Novel Therapeutic Approaches for NF1 Deficient Peripheral Nerve Sheath Tumors
Malignant Peripheral Nerve Sheath Tumors (MPNSTs) associated with Neurofibromatosis Type 1 (NF1) pose a significant clinical challenge due to their aggressive nature and limited treatment options. This thesis endeavors to address this challenge by developing innovative therapeutic approaches for …
-
Multiomic Analyses Reveal Epigenomic Alterations and New Targets of Polycomb Repressive Complex 2 in Schwann Lineage Cells and Malignant Peripheral Nerve Sheath Tumors
… Type I (NF1) patients. It is thought that MPNSTs develop from benign precursors. However, the existing histologically defined stages in MPNST development need improvement. Commonly, MPNSTs harbor defects in PRC2 components EED or SUZ12, leading to loss of trimethylation of histone H3 on …
-
Determining the role of neuregulin-1 and its erbB receptors in the pathogenesis of malignant peripheral nerve sheath tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are the most common cause of death in patients with neurofibromatosis type-1. These aggressive, Schwann cell-derived tumors have no treatment beyond surgical resection. Developing targeted chemotherapeutics remains crucial to improving patient …
-
Mechanisms of AT101 [(-)-Gossypol] Induced Cytotoxicity in Malignant Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived sarcomas and are the leading cause of mortality in patients with neurofibromatosis type 1 (NF1). Current treatment modalities have been largely ineffective resulting in a high rate of MPNST recurrence and poor …
-
Pathogenesis of neurofibromatosis 1 associated neurofibromas
… NF1. Malignant peripheral nerve sheath tumours (MPNSTs) are one of the leading causes of death in people with NF1. Clinical evidence suggests that most MPNSTs develop from pre-existing plexiform neurofibromas. Most studies treat all NF1-associated neurofibromas as a single entity, ignoring …
-
Mechanisms Of Resistance To Oncolytic Herpes Simplex Viruses In Malignant Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are rare but highly aggressive cancer of the peripheral nervous tissue. Median patient survival is approximately two years following diagnosis due in part to the ineffective options for treatment. As an alternative therapeutic approach to …
-
The Role of Bcl-xL and EGFR in the Malignant Progression of Neurofibromatosis type 1
… to malignant peripheral nerve sheet tumors (MPNSTs) in patients with NF1 is notable and is of far greater concern because MPNSTs are a type of aggressive sarcoma and are a major cause of mortality in patients with NF1. Yet the pathogenesis is poorly understood. In addition to the NF1 …
-
Molecular Characterization of the Spectrum of Peripheral Nerve Sheath Tumors
… examined the genomic and epigenomic drivers of MPNSTs, analyzing 108 tumors spanning the full spectrum of peripheral nerve sheath tumors, using a multiplatform integrated approach to identify drivers of MPNST. We established through multiple unsupervised analyses of methylome and transcriptome …
-
Regulation Of Cell Death By Autophagy In Glial Neoplasms
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive malignancies of the peripheral nervous system. The majority of MPNSTs arise in patients of the autosomal dominant genetic disorder neurofibromatosis type I (NF1) although they also arise sporadically. In the absence of any effective …
-
Identification of genes and pathways involved in Schwann cell tumor initiation, development and progression to develop novel drug targets
… body. Malignant peripheral nerve sheath tumors (MPNSTs) are tumors composed of Schwann cells that have acquired these oncogenic characteristics. MPNSTs occur spontaneously in the general population at a rate of 1 in 100,000 people per year, but more commonly occur in the context of …
-
A Collagen Droplet Platform For Screening Malignant Peripheral Nerve Sheath Tumors
… platform for utilization with ex vivo PDX MPNSTs. The platform is then utilized for a single and dual drug screen to probe for potential future therapeutic agents based on cellular viability over time. We culminate these studies by presenting a repository of ex vivo PDX MPNSTs across …
-
Functional translation of malignant peripheral nerve sheath tumour driver gene variants using CRISPR screens
<p>Malignant peripheral nerve sheath tumours (MPNSTs) are aggressive neural-crest cell derived sarcoma with limited treatment options, and only margin-free surgery as a potentially curative treatment option. The dire prognosis of these patients warrants the need for novel therapeutics. The …
-
The role of IFITM1 in malignant progression of neurofibromas in NF1
… to malignant peripheral nerve sheath tumors (MPNSTs) remained unclear, genetic and epigenetic changes involved in MPNST pathogenesis. Here I found that interferon-induced transmembrane protein 1 (IFITM1) was downregulated in MPNST tissues compared to that in PN tissues from NF1 patients by …
-
Investigation of Molecular Therapeutic Targets in Malignant Peripheral Nerve Sheath Tumors
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive softtissue sarcomas that commonly arise in patients with Neurofibromatosis Type I (NF1) syndrome. These tumors primarily follow a genetic etiology of successive tumor suppressor loss; first, loss of NF1, followed by loss of CDKN2A or …
-
RMC-7977: A PROMISING INHIBITOR FOR THE TREATMENT OF NF1-RELATED TUMORS
… malignant peripheral nerve sheath tumors (MPNSTs), and gliomas. Despite advances in our understanding of NF1-associated tumor biology, current treatment options remain limited, especially for MPNSTs and high-grade gliomas. RMC-7977, a novel tri-complex pan-RAS inhibitor, selectively targets …
-
Identification of transcriptional mechanisms downstream of nf1 gene defeciency in malignant peripheral nerve sheath tumors
… have a significant risk of developing into MPNSTs leading to increased morbidity and mortality from this syndrome. Surgery is the primary intervention but it is not always effective due to the tendency of MPNSTs to infiltrate the surrounding tissue or grow in an inoperable location. …
-
Modification of RHAMM and TPX2 optimizes Aurora kinase A (AURKA) inhibition in malignant peripheral nerve sheath tumours
… associated with neurofibromatosis type I. MPNSTs lack effective treatments as they often resist chemotherapies and have high rates of disease recurrence. Published analysis of copy number variation identified hemizygous loss of Hyaluronan Mediated Motility Receptor (HMMR, encodes RHAMM) in …
-
Modellorganismen und Genomik in der Krebsforschung
… von malignen peripheren Nervenscheidentumoren (MPNSTs) des Zebrafischs (Danio rerio). Die Datenanalyse zeigte, dass Zebrafisch-MPNSTs chromosomale und subchromosomale Veränderungen aufweisen, ähnlich solchen, die auch von menschlichen Tumoren (einschließlich MPNSTs) einschlägig dokumentiert …
Page 1 of 2